- Report
- October 2025
- 160 Pages
Global
From €2871EUR$3,160USD£2,468GBP
€3589EUR$3,950USD£3,085GBP
- Report
- October 2025
- 160 Pages
Global
From €2871EUR$3,160USD£2,468GBP
€3589EUR$3,950USD£3,085GBP
- Report
- October 2025
- 160 Pages
Global
From €2871EUR$3,160USD£2,468GBP
€3589EUR$3,950USD£3,085GBP
- Report
- October 2025
- 160 Pages
Global
From €2871EUR$3,160USD£2,468GBP
€3589EUR$3,950USD£3,085GBP
- Report
- July 2026
- 140 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- June 2026
- 130 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- February 2026
- 187 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- October 2025
- 150 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- March 2026
- 79 Pages
Africa, Middle East
From €3135EUR$3,450USD£2,694GBP
- Report
- March 2026
- 99 Pages
Europe
From €3589EUR$3,950USD£3,085GBP
- Report
- March 2026
- 94 Pages
Asia Pacific
From €3589EUR$3,950USD£3,085GBP
- Report
- August 2026
- 200 Pages
Japan
From €2263EUR$2,490USD£1,945GBP
- Report
- August 2025
- 200 Pages
United States
From €2263EUR$2,490USD£1,945GBP
- Report
- August 2025
- 150 Pages
Global
From €5406EUR$5,950USD£4,647GBP
- Report
- July 2025
- 150 Pages
Global
From €3407EUR$3,750USD£2,929GBP
- Report
- April 2026
- 100 Pages
Spain
From €4316EUR$4,750USD£3,710GBP
- Report
- March 2026
- 200 Pages
Saudi Arabia
From €2534EUR$2,789USD£2,178GBP
- Report
- June 2025
- 300 Pages
Europe
From €3516EUR$3,869USD£3,022GBP
- Report
- February 2025
- 149 Pages
Global
From €3589EUR$3,950USD£3,085GBP
- Report
- July 2024
- 156 Pages
Global
From €3089EUR$3,400USD£2,655GBP
€3862EUR$4,250USD£3,319GBP

The Transcatheter Valve Replacement (TVR) market is a subset of the Cardiovascular Devices market. It is a minimally invasive procedure used to replace a diseased or damaged heart valve. The procedure involves inserting a catheter into the patient's body and guiding it to the heart, where the new valve is then deployed. The procedure is less invasive than traditional open-heart surgery, and is often used to treat patients who are at high risk for complications from open-heart surgery.
TVR is a rapidly growing market, with new technologies and procedures being developed to improve patient outcomes. The market is expected to continue to grow as more patients are able to benefit from the procedure.
Some of the companies in the TVR market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and St. Jude Medical. Show Less Read more